Header Logo

Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity.

Kumar NP, Fukutani KF, Shruthi BS, Alves T, Silveira-Mattos PS, Rocha MS, West K, Natarajan M, Viswanathan V, Babu S, Andrade BB, Kornfeld H. Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity. Elife. 2019 07 04; 8.

View in: PubMed